MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/mt.2010.265

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2010

Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.

Ellinwood N Matthew, Ausseil Jérôme, Desmaris Nathalie, Bigou Stéphanie, Liu Song, Jens Jackie K, Snella Elizabeth M, Mohammed Eman E A, Thomson Christopher B, Raoul Sylvie, Joussemet Béatrice, Roux Françoise, Chérel Yan, Lajat Yaouen, Piraud Monique, Benchaouir Rachid, Hermening Stephan, Petry Harald, Froissart Roseline, Tardieu Marc, Ciron Carine, Moullier Philippe, Parkes Jennifer, Kline Karen L, Maire Irène, Vanier Marie-Thérèse, Heard Jean-Michel, Colle Marie-Anne

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Recent trials in patients with neurodegenerative diseases documented the safety of gene therapy based on adeno-associated virus (AAV) vectors deposited into the brain. Inborn errors of the metabolism are the most frequent causes of neurodegeneration in pre-adulthood. In Sanfilippo syndrome, a lysosomal storage disease in which heparan sulfate oligosaccharides accumulate, the onset of clinical manifestation is before 5 years. Studies in the mouse model showed that gene therapy providing the missing enzyme α-N-acetyl-glucosaminidase to brain cells prevents neurodegeneration and improves behavior. We now document safety and efficacy in affected dogs. Animals received eight deposits of a serotype 5 AAV vector, including vector prepared in insect Sf9 cells. As shown previously in dogs with the closely related Hurler syndrome, immunosuppression was necessary to prevent neuroinflammation and elimination of transduced cells. In immunosuppressed dogs, vector was efficiently delivered throughout the brain, induced α-N-acetyl-glucosaminidase production, cleared stored compounds and storage lesions. The suitability of the procedure for clinical application was further assessed in Hurler dogs, providing information on reproducibility, tolerance, appropriate vector type and dosage, and optimal age for treatment in a total number of 25 treated dogs. Results strongly support projects of human trials aimed at assessing this treatment in Sanfilippo syndrome.

Для цитирования: Ellinwood N Matthew, Ausseil Jérôme, Desmaris Nathalie, Bigou Stéphanie, Liu Song, Jens Jackie K, Snella Elizabeth M, Mohammed Eman E A, Thomson Christopher B, Raoul Sylvie, Joussemet Béatrice, Roux Françoise, Chérel Yan, Lajat Yaouen, Piraud Monique, Benchaouir Rachid, Hermening Stephan, Petry Harald, Froissart Roseline, Tardieu Marc, Ciron Carine, Moullier Philippe, Parkes Jennifer, Kline Karen L, Maire Irène, Vanier Marie-Thérèse, Heard Jean-Michel, Colle Marie-Anne. Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.. Molecular therapy : the journal of the American Society of Gene Therapy. 2010. DOI: 10.1038/mt.2010.265.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.